Last updated:
Psilocybe Bohemica
"Bohemian Psilocybe"
![[object Object]](https://d16q8n2b2c01ef.cloudfront.net/media/PsilocybeBohemica-1_new-800x450.webp)
Scientific Classification
About
Psilocybe bohemica, commonly referred to as the Bohemian Psilocybe, is a potent psilocybin mushroom native to Central Europe, particularly the Czech Republic, where it was first described. Often confused with Psilocybe serbica and Psilocybe cyanescens, this species is notable for its strong psychoactive effects, wavy cap margin, and growth in woody, decaying plant matter—particularly in coniferous forests.
History
P. bohemica was first identified in Bohemia (now part of the Czech Republic) in 1983. Initially categorized separately, it is now considered by many mycologists to be a synonym of Psilocybe serbica due to molecular similarity. Regardless of classification, the name "Bohemian Psilocybe" remains widely used to describe mushrooms from this region with intensely visual and cerebral psychedelic effects.
It has been a focal point for European mycophiles seeking wild, naturally growing entheogenic species.
Overview
The mushroom has a bell-shaped to conical cap, ranging from 1.5 to 5 cm in diameter, caramel to golden brown in color, and hygrophanous (fades as it dries). The gills are dark purplish-brown, and the stem is thin, flexible, and bruises deep blue when handled—an indicator of high psilocybin content.
Its effects are highly psychedelic, featuring strong visual distortions, auditory enhancements, altered perception of time, and deep introspection. It is typically consumed dried and is sought after for personal exploration, nature immersion, and therapeutic journeys, though it requires proper identification due to confusion with toxic look-alikes.
Physical Characteristics
Caps:
Convex to broadly convex, sometimes with a slight umbo, smooth, with a gelatinous layer when moist
Gills:
Adnate to adnexed, close, dark purple-brown with spore maturity
Psychoactive Effects
Euphoric
Describing intense feelings of happiness or excitement
Perceptual
The change in the way things are perceived, including changes in time perception, spatial perception, and perception of one's own body.
Pharmacology
Helps With
Depression
Relieves symptoms of depression, improving mood and outlook
Anxiety
Helps to alleviate feelings of worry, fear, and unease
Addiction
Helps to overcome addiction and substance abuse
PTSD
Helps to alleviate symptoms of post-traumatic stress disorder
OCD
Helps to alleviate symptoms of obsessive-compulsive disorder
ADD ADHD
Helps to alleviate symptoms of attention deficit disorder and attention deficit hyperactivity disorder
Pain
Microdosing psilocybin has been shown to help with certain types of pain
Migraines
Research shows that psilocybin, the active compound in magic mushrooms, has potential therapeutic benefits for migraines. A small-scale study conducted by Yale School of Medicine found that a single dose of psilocybin reduced the likelihood of having a migraine attack in two weeks.
Possible Side Effects
Nausea
A feeling of discomfort in the stomach with an urge to vomit
Grow at Home
Start your cultivation journey with quality grow kits from verified vendors
Chemical Constituents
Medicinal Chemistry
Mushroom Ratings
0.0
Based on 0 Reviews
5
★4
★3
★2
★1
★Share your thoughts
If you've consumed this mushroom, share your thoughts with our community
References
- Sekssaoui, M. (2024). Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?. .
- Ley, L. (2023). Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. .
- Bae, S. (2023). Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis. .
- Schindler, E. (2022 ). Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial. .
- Barrett, F. (2022). Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation. .
- Desai, S. (2022). Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users—A National Survey Study. .
- Rucker, J. (2021). Psilocybin: From Serendipity to Credibility?. .
- Schindler, E. (2021). Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin. .
- Raval, N. (2021). A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain. .
- Kuypers, K. (2019). Psychedelic medicine: The biology underlying the persisting psychedelic effects. .